...
首页> 外文期刊>Journal of medical biography >Robert Furchgott (1916-2009): A scientist with a mission
【24h】

Robert Furchgott (1916-2009): A scientist with a mission

机译:Robert Furchgott(1916-2009):一个有代表团的科学家

获取原文
获取原文并翻译 | 示例
           

摘要

Robert Furchgott was first noted for research on drug–receptor theory, autonomic neuroeffector mechanisms, and vascular pharmacology/physiology. His studies on drug–receptor interactions provided important knowledge about the properties of drug receptors long before methodologies were developed to study them directly. However, Furchgott achieved an enduring legacy for recognizing the importance of endothelial cells for the relaxation of vascular smooth muscle. On the basis of his own experiments and those of others, he proposed that acetylcholine interacted with muscarinic receptors at the surface of endothelial cells to release a substance called endothelium relaxing factor. Endothelium relaxing factor was later identified as nitric oxide, a colorless, odorless gas. Furchgott’s discovery of an entirely new mechanism by which blood vessels dilate revolutionized studies on the physiology of the vascular system. His work also suggested new treatments for hypertension and heart disease, and was a key factor in the development of the anti-impotence drug sildenafil. In 1998, Robert Furchgott shared the Nobel Prize in Physiology or Medicine with Ferid Murad and Louis Ignarro.
机译:Robert Furchgott最早因研究药物受体理论、自主神经效应机制和血管药理学/生理学而闻名。早在开发直接研究药物受体的方法之前,他对药物-受体相互作用的研究就提供了有关药物受体特性的重要知识。然而,弗希戈特在认识到内皮细胞对血管平滑肌松弛的重要性方面取得了不朽的成就。在他自己和其他人的实验基础上,他提出乙酰胆碱与内皮细胞表面的毒蕈碱受体相互作用,释放一种叫做内皮舒张因子的物质。内皮舒张因子后来被鉴定为一氧化氮,一种无色无味的气体。Furchgott发现了一种全新的血管扩张机制,这彻底改变了血管系统生理学的研究。他的研究还提出了治疗高血压和心脏病的新方法,也是抗阳痿药物西地那非研发的关键因素。1998年,罗伯特·弗希戈特与费里德·穆拉德和路易斯·伊格纳罗共同获得诺贝尔生理学或医学奖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号